Biosimilars and Interchangeable Biologics
What's the Deal with Biosimilars?Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property…
Mehr
CHF 81.25
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-1-4987-4350-1
- EAN: 9781498743501
- Produktnummer: 19557385
- Verlag: Crc Press
- Sprache: Englisch
- Erscheinungsjahr: 2016
- Seitenangabe: 575 S.
- Plattform: PDF
- Masse: 0 KB
Über den Autor
Sarfaraz K. Niazi, PhD, is the founding executive chairman of Therapeutic Proteins International LLC, a world-class pure-play developer and manufacturer of biosimilar and interchangeable recombinant biologics, headquartered in Chicago. Dr. Niazi began his career teaching pharmacy at the University of Illinois (1972-1988), where he became a tenured professor. He then entered the pharmaceutical industry at Abbott International, becoming a Volwiler Fellow. He left Abbott in 1995 with a passion for making high-cost biological drugs affordable. Dr. Niazi set up several ex-U.S. biosimilar companies and, in 2003, established Therapeutic Proteins International, the only U.S. integrated company of its kind to date.
59 weitere Werke von Sarfaraz K. Niazi:
Handbook of Pharmaceutical Manufacturing Formulations, Third Edition
Ebook (EPUB Format)
CHF 1,175.20
Handbook of Pharmaceutical Manufacturing Formulations, Third Edition
Ebook (PDF Format)
CHF 1,175.20
Bewertungen
Anmelden